Flavay Plus® is a synergistic blend of the highest-quality,
all-natural ingredients; providing you and your family with
the best that nutritional science has to offer in a safe,
convenient and cost effective capsule.
What is Flavay Plus®?
Until recently many believed that each antioxidant worked separately
in the body, independently of the others. We now know that isn't
true. Flavay® recycles and significantly extends the lifetime
of vitamin C, potentiates vitamin E, and thereby creates a more
powerful, synergistic antioxidant effect in the body. Current
research also demonstrates that other antioxidants work as a
team, in sequence and in a complementary fashion.
Flavay Plus® utilizes this dynamic
with a synergistic blend of Flavay® and antioxidant vitamins
and minerals and phytonutrients; formulated to especially boost
the brain and immune functions—thereby benefiting the whole
body.
Flavay®: a very specific,
standardized and isolated, singular polyphenol complex defined
and perfected by Dr. Jack Masquelier in France; validated by
the French Ministry of Health and documented by a library of
research consisting of many patents and hundreds of scientific
papers, articles, doctorate theses, lectures and presentations.
Flavay® is a powerfully effective ANTIOXIDANT
that recycles other antioxidants in the body after they
have quenched corrosive free radicals which affect many
tissues and conditions including cognitive impairment
and premature aging.
Flavay® helps to regulate the good-bad free
radical, NITRIC OXIDE, which is essential for: normal
blood circulation, coordinating activity between the
immune system and the brain, and modulating communication
between brain cells—and is thereby deeply involved
in concentration, learning and memory.
Flavay® inhibits the release and synthesis of
HISTAMINE, a key factor in the promotion of INFLAMMATION;
reactions associated with conditions like vascular diseases,
allergies, and arthritis.
Flavay® strengthens and rebuilds COLLAGEN proteins,
improving skin and blood vessel health.
Phosphatidyl Serine: A naturally
occurring fatty acid in the brain, the phosphatidyl serine (Leci-PS™)
in Flavay Plus® is a natural complex of phospholipid nutrients
and fatty acids derived from soy lecithin. Thousands of published
research papers, including many published in peer-reviewed mainstream
scientific journals, at least 64 of which were clinical studies
on humans, show that phosphatidyl serine supplementation works
consistently for the brain and benefits virtually every brain
function. By boosting membrane functions in cells throughout
the brain, phosphatidyl serine seems to boost many nerve transmitters
while simultaneously boosting their coordinated effects across
the entire brain.
Ginkgo Biloba: The standardized
extract of the ginkgo leaves has been shown to be beneficial
in a broad range of conditions, including those involved with
circulation, blood conditions, metabolism, immune function,
varicose conditions, and post-thrombotic syndrome. It has been
shown to help with short-term memory improvement (especially
in older populations), and cognitive disorders secondary to
depression, among other conditions. Flavay Plus® uses
the clinically proven optimum ratios of standardized ginkgo
leaf extract that were used in the breakthrough study published
in the Journal of the American Medical Association.
GABA: One of the most abundant
neurotransmitters in the brain, some people with anxiety, panic
disorders, and depression may not manufacture sufficient levels
of GABA.
VITAMIN A (as Beta-carotene):
Flavay Plus is formulated with the preferred form of vitamin
A, beta-carotene (Betatene™) which is converted into vitamin
A only as the body needs it. What isn’t converted to vitamin
A remains as a powerful antioxidant, shown to be a cancer preventative,
to help strengthen the immune system, to reduce the risk of
atherosclerosis, heart attack and stroke, and protect against
macular degeneration and the formation of cataracts. Flavay
Plus™ provides the highest quality, full-spectrum, patented
Betatene™, a complete array of plant-derived, antioxidant
carotenoids: beta-carotene, alpha-carotene, cryptoxanthin, zeaxanthin,
lutein, and lycopene.
Vitamin B-1 (Thiamin): Plays
an essential role in the metabolism of carbohydrates in the
body, improves mental attitude, and keeps the nervous system,
muscles and heart functioning normally. Inadequate intake may
result in mental illness and some psychiatrists use vitamin
B-1 for various emotional and psychiatric illnesses, oftentimes
with medication.
VITAMIN B-2 (Riboflavin):
Assists in energy metabolism, fatty and amino acid synthesis.
Vitamin B-2 is needed for tissue repair and is sometimes called
the “growth vitamin.” Inadequate intake may cause
depression, moodiness, nervousness, and irritability.
Vitamin B-6 (Pyridoxine):
Involved in the metabolism of amino acids (the building blocks
of proteins) and of essential fatty acids, the nervous system
is dependent on vitamin B-6 for the production of GABA and neurotransmitters
in the brain, such as serotonin and dopamine. It may be difficult
for men and women to obtain even the RDAs from food; and stress,
medications, smoking, and pollutants raise the B-6 requirement.
Inadequate intake is associated with depression, confusion,
dizziness, insomnia, irritability, and nervousness.
Vitamin B-12 (Cyanocobalamin):
Helps the body to utilize fats, carbohydrates and protein; and
to maintain a healthy nervous system. Vitamin B-12 increases
energy, relieves irritability, and improves concentration, memory
and balance. Vitamin B-12 also helps the body to form and regenerate
red blood cells and to break down homocysteine, a risk factor
in heart disease. In children, B-12 supports growth.
Vitamin C: Water-soluble,
a potent free radical scavenger and it recycles vitamin E in
the body. Vitamin C plays a primary role in the formation of
collagen and it is essential for a healthy cardiovascular system
and a strong immune system. Controlled studies prove the contribution
of vitamin C in the manufacture of white blood cells and interferon. It's also important to note that Flavay®
dramatically extends the activity of vitamin C in the body.
Vitamin E: The body’s
principal fat-soluble antioxidant. Much of the body’s
free radical damage occurs in fats and in fatty membranes of
cells—exactly where vitamin E protects the body. Vitamin
E is used by surgeons before and after operations to ensure
against thrombosis and increase immunity to infection, by pediatricians
to prevent blindness in premature babies, and by other specialists
to increase high-density lipoproteins. Vitamin E decreases elevated
hormone levels and prevents and treats anemias.
Flavay Plus® uses only natural, cold-water dispersible
(dry) vitamin E because it is efficiently absorbed even when
taken on an empty stomach or with a low-fat meal. The other
forms of natural vitmain E, the non-cold water dispersible (oil)
forms, may be poorly absorbed unless taken with several grams
of fats or oils.
The National Academy of Science officially recognized natural
vitamin E (d-alpha) as twice as potent and retained twice as
well as synthetic (dl-alpha). This means twice as much natural
vitamin E reaches the blood and organs compared to synthetic
versions.
Selenium: Necessary for the
body’s production of its own, naturally occurring antioxidants
including: glutathione (a key intracellular antioxidant enzyme
system that is responsible for protecting all of the body’s
cells from free radical damage and detoxifying noxious agents
from the body) and thioredoxin reductase, which recycles vitamin
C. Selenium also has a synergistic effect with vitamin E, which
means that the two combined are more powerful than either alone.
Many Americans do not consume even the small RDA of selenium
in their diet. Not consuming enough selenium is dangerous to
your health. Low blood levels of selenium have been strongly
associated with an increased risk of heart attack, stroke, and
many different types of cancer.
Zinc: An essential mineral,
zinc has many important effects on the brain and immune system,
including neurotransmitter production and enzyme functioning.
Zinc is a necessary part of the body’s production of DHA
and a constituent of many vital enzymes, including superoxide
dismutase (SOD), which is a critical cellular antioxidant enzyme
that is responsible for mopping up peroxynitrate, the highly
toxic free radical produced in abundance in the normal course
of immune system battles (as in viral or bacterial infections)
and plays a powerful role in immune system inflammation. Together
with the B vitamins, zinc assists in the utilization of insulin
and glucose. There is a growing body of evidence to indicate
that zinc is needed for the proper maintenance of vitamin E
levels in the blood and aids in the absorption of vitamin A.
Other important functions of zinc include the promotion of glandular
and reproductive health; and there is strong evidence that zinc
is required for the synthesis of the nucleic acids RNA and DNA,
which are essential for cell repair and cell growth. Studies
have found large percentages of apparently healthy children
to be deficient in zinc. There is evidence that zinc levels
fall after physical and mental stress. Flavay Plus® uses
zinc orotate, a high-quality, highly bioavailable form of zinc.
Synergistic Benefits in One
Capsule
Flavay Plus® is a synergistic blend of the above ingredients—all
naturally derived and from the highest quality sources; providing
you and your family with the best that nutritional science has
to offer in a safe, convenient and cost effective capsule.
Statements made herein have not been
evaluated by the Food and Drug Administration. These products are not intended
to diagnose, treat, cure or prevent any disease.
Masquelier, J. Plant extract
with a proanthocyanidins content as a therapeutic agent having
radical scavenging effect and use thereof. U.S. Patent No. 4,698,360,
1987.
Masquelier, J. A lifetime devoted to OPC and Pycnogenols. Alfa
Omega Editrice, Pub., 1996.
Schwitters, B., Masquelier, J. OPC in practice. Alfa Omega Editrice,
Publishers, 1995.
Kilham, C., Masquelier, J. OPC: The miracle antioxidant. Keats
Publishing, Inc., 1997.
Mindell, E., et al. Earl Mindell’s vitamin bible for the
21st century. Warner Books, Inc., 1999.
Passwater, R.A. The antioxidants: the nutrients that guard your
body. Keats Publishing, Inc., 1985.
Barilla, J. et al. The nutrition superbook: volume 1: the antioxidants.
Keats Publishing, Inc., 1995.
Lieberman, S., et al. The real vitamin & mineral book: going
beyond the RDA. Avery Pub., 1990.
___. Inadequate intake of vitamins, particularly B-1, can result
in mental illness. Clin. Neuro, 8 (Jul.--Sep. 1985):286-293.
___. Carpal tunnel syndrome treated with riboflavin and pyridoxine.
Proceedings of the Nat. Acad. of Sc. 81 (Nov. 1984):7076-8.
___. High calorie diets with disproportionately low intakes of
vitamins and minerals may be the source of widespread marginal
malnutrition. Journ of the Amer Col of Nut, 7 (1988):61-67.
Facino RM, et al. Free radical scavenging action and anti-enzyme
activities of procyanidines from Vitis vinifera. A mechanism for
their capillary protective action. Arzneimittelforschung, 44:
592-601, 1994.
Kuttan R, et al. Collagen treated with catechin becomes resistant
to the action of mammalian collagenase. Experientia, 37: 221-223,
1981.
Masquelier, J., et al. Stabilization du collagene par les oligomeres
procyanidoliques. Acta Therapeutica, 7:101-105, 1981.
Masquelier, J. Aspects pharmacologiques nouveaux de certains flavonoides.
A Vie Medical 12:1969.
Laparra, J., et al. Etude pharmaco-cinetique des oligomers procyandoliques
totaux du raisin. Acta Therapeutica, 4, 1978.
Laparra, J., et al. Etude pharmacocinetique des oligomeres flavonoliques.
Plantes med et phyto, Tome XI, pp. 133-142, 1977.
Robert A.M.; Groult, N.; Six, C.; Robert, L. Etude de l’action
des oligomeres procyanidoliques sur des cellules mesenchymateuses
en culture. Ii l’attachment des fibres elastiques aux cellules.
(Study of the effect of procyanidolic oligomers on mesenchymal
cells in culture. Ii attachment of elastic fibers to the cells.)
Pat Biol, (30)6:601-7, 1990.
Porter, Lawrence J., Wong Rosalind Y. Chan, Bock G. The molecular
and crystal structure of (+)-2,3-trans-3,4-trans-leucocyanidin
[(2r,3s,+r)-(+)-3,3’, 4.4’, 5.7’-Hexahydroxyflavan]
dihydrate, and comparison of its heterocyclic ring conformation
in solution and the solid state. Journal of the Chemical Society;
Perkin Transactions I 1985. pp. 1413-17.
Masquelier, J. Proanthocyanidins et radicaux libres. 1985.
Uchida, S., et al. Condensed tannins scavenge active oxygen free
radicals. Med Sci Res, (15) 1987. pp. 831-832.
Ariga, T. Radical scavenging action and its mode in procyanidins
b-1 and b-3 from azuki beans to peroxyl radicals. Agric Biol Chem,
54(10) 1990. pp. 2499-2504.
Da Silva, R., et. al. Radical scavenger capacity of different
procyanidins from grape seeds. Presented at a symposium, “Free
radicals in biotechnology and medicine.” Royal Society Of
Chemistry, London January 1990, pp. 79-80.
Bauman, J., Wurm, G., Bruchhausen, F. “Hemmung der prostagladinsynthetase
durch flavonoide und phenolderivate im vergleich nit deren 02
radikalfangereigenschaften” Arch Pharm, (Weinheim) 313 (1980)
pp. 330-337.
Lombard, J., et al. The brain wellness plan. Kensington Pub. Corp.,
1998.
Kidd, P.M. Phosphatidylserine: the nutrient that accelerates all
brain functions and counters Alzheimer’s disease: Keats Pub.
1998.
Cenacchi T, et al. Cognitive decline in the elderly: A double-blind,
placebo-controlled multicenter study on efficacy of phosphatidylserine
administration. Aging, 5: 123–133, 1993.
Maggioni M, Picotti GB, Bondiolotti GP et al. Effects of phosphatidylserine
therapy in geriatric patients with depressive disorders. Acta
Psychiatr Scand. 81: 265–270, 1990.
Brambilla, F., Maggioni, M., Panerai, A.E., et al. Beta-endorphin
concentration in peripheral blood mononuclear cells of elderly
depressed patients—effects of phosphatidylserine therapy.
Neuropsychobiology, 34: 18–21, 1996.
Monteleone P., Maj M., Beinat L., Natale M., Kemali, D. Blunting
by chronic phosphatidylserine administration of the stress-induced
activation of the hypothalamo-pituitary-adrenal axis in healthy
men. Eur J Clin Pharm, 43: 385–388, 1992.
Cenacchi T, et al., “Cognitive decline in the elderly: A
double-blind, placebo-controlled multicenter study on efficacy
of phosphatidylserine administration.” Aging, 5, 123-133,
1993
Funfgeld, E.W., Baggen, M., Nedwidek, P., Richstein, B., Mistlberger,
G. Double-blind study with phosphatidylserine (PS) in parkinsonian
patients with senile dementia of Alzheimer’s type (SDAT).
Prog Clin Biol Res, 317:1235-46, 1989.
Le Bars, P.L., Katz, M.M., Berman, N., Itil, T.M., Freedman, A.M.,
Schatzberg, F.A. A placebo-controlled, double-blind, randomized
trial of an extract of ginkgo biloba for dementia. Journal of
the Amer Med Assoc, 278 (16):1327-32, 1997.
Waagepetersen, H.S., Sonnewald, U., Schousboe, A. The GABA paradox:
multiple roles as metabolite, neurotransmitter, and neurodifferentiative
agent. J Neurochem, 73:1335–42, 1999.
Goddard, A.W., Mason, G.F., Almai, A., Rothman, D.L., Behar, K.L.,
Petroff, O.A.C., Charney, D.S., Krystal, J.H. Reductions in occipital
cortex gaba levels in panic disorder detected with h-magnetic
resonance spectroscopy. Arch Gen Psychiatry, 58:556-561, 2001.
Braverman, E., et al. The healing nutrients within: in facts,
findings and new research. Keats, 1987.
Cavagnini, F., et al. Effect of acute and repeated administration
of gamma aminobutyric acid (GABA) on growth hormone and prolactin
secretion in man. Acta Endocrinol, 93:149–54, 1980.
Bhagavan, H.N., et al. The effect of pyridoxine hydrochloride
on blood serotonin and pyridoxal phosphate contents in hyperactive
children. Pediatrics, 1975;55: 437-41.
___. Along with riboflavin, vitamin B-6 deficiency has a primary
role in the cause of emotional disorder. British Journal of Psychiatry,
141(1982):271-272.
___. Current data suggest that as many as 20 percent of medically
cleared population of outpatient depressives may suffer from a
vitamin B-6 deficit. The authors point out that nutrition, diet
and vitamin levels have received very little attention in the
psychiatric literature. Biological Psychiatry, 9:4 (1984):613-6.
___. Does depressive illness cause vitamin B-6 inadequacy, or
vice-versa? Nut Rep Int, 27 (Apr. 1993):867-873.
Martineau, J., et al. Vit. B6, magnesium, and combined B6-Mg:
therapeutic effects. Bio Psy, 20:467-78, 1985.
Dolphin, et al. (eds). Vitamin B6: pyridoxal phosphate. John Wiley
& Sons, 1986, chapt. 17.
Langseth, L., et al. Glucose tolerance and hyperkinesis. Food
and Cosm Toxicology, 16 Aug. 1977.
O’Brien, C. Answers to ADD. Vitamin Retailer, March 2002.
Facino, R.M., et al. Free radical scavenging action and anti-enzyme
activities of procyanidines from vitis vinifera. A mechanism for
their capillary protective action. Arzneimittelforschung, 44:
592-601, 1994.
Kuttan, R., Donnelly, P.V., Di Ferrante, N. Collagen treated with
catechin becomes resistant to the action of mammalian collagenase.
Experientia, 37: 221-223, 1981.
Masquelier, J. Procyanidolic oligomers. J Parums Cosm Arom, 95:
89-97, 1990.
Tixier, J.M., et al. Evidence by in vivo and in vitro studies
that binding of pycnogenols to elastin affects its rate of degradation
by elastases. Biochem Pharmacol, 33: 3933-3939, 1984.
Kakegawa, H., et al. Chem. Pharm. Bull. 33:5079, 1985.
Harmand, M.F., Blanquet, P. The fate of total flavanolic oligomers
extracted from ‘vitus vinifera l.’ in the rat. European
Journal of Drug Metabolism and Pharmaccokinetics. 1978, No. 1
pp. 15-30.
Delrieu, P., Ding J., Escande, B., Samain, D. Free-radical scavenging
activity of proanthocyanidolic oligomers encapsulated in glycospheres:
an in vivo and in vitro study. Cosmetology Department & S
Biovectors, Ramonville St. Agne France. pp. 1-9.
Meunier, M.T., Villie, F., et al. Inhibition of angiotensin i
converting enzyme by flavanolic compounds: in vitro and in vivo
studies. Planta Medica, May 26, 1986. pp. 12-15.
Barbier, A., et al. Activite angioprotectrice des oligomeres procyanidolques
chez l’animal-oedenme de la patte. Sanofi Res Toul Cedex
Fr, pp31-40.
Barbier, A., et al. Activite angioprotectrice des oligomeres procyanidolques
chez l’animal-activite aniagoniste vis-a-vis des mediateurs
de l’inflamation. Sanofi Res Toul Cedex Fr, pp. 31-40.
Dubos, C., Durst, G., Hugonot, H. Evolution de la resistance capillaire,
spontanement ou artificiellement diminuee par l’action d’une
substance capillaro-toxique chez des personnes agees--action benefique
d’un agnet actif sur la micro-circulation: l’Endotelon.
Inform. Therapeut. 1980. pp. 302-305.
Dartenuc, J.Y., et al. Resistance capillaire en geriatrie etude
d’un microangioprotecteur-Endotelon. Bordeaux Med. 13:903-7,
1990.
Lagrue, G., Olivier-Martin, F., Grillot, A. “Etude des effets
des oligomeres du procyanidol sur las resistance capillaire dand
l’hypertension arterielle et certaines nephropathies.”
Sen. Hosp. Paris 18-25 Septembre, 1981.
Beylot, C., Bioulac, P. Essai therapeutique d’un angioprotecteur
peripherique, l’Endotelon. Actualite Therapeutique Gaz. Med.
de France (87)22:2919-24, 1980.
Lesbre, F.X., Tigaud, J.D. Effect de l’Endotelon sur l’indice
de fragilite capillaire dan une population specifique: les sujets
cirrhotiques. Gaz. Med. de France, (90)24 1983.
Sarrat, L. Abord therapeutique des troubles fonctionnels des membres
inferieurs par un microangioprotecteur l’Endotelon. Bordeaux
Med, 11:685-8, 1981.
Delacroix, P. Etude en double aveugle de l’Endotelon dans
l’insuffisance veineuse chronique. Therapeutique, la Revue
de Medicine, (27-28) Sept. 1981. pp. 1793-1802.
Thebaut, J.F, Thebaut, P., Vin, F. Etude de l’Endotelon dand
les manifestations fonctionnelles de l’insuffisance veineuse
peripherique-resultats d’une etude en double aveugle portant
sur 92 patients.” Gazette Medicale, (92)1, 1985. pp. 96-100.
Wegrowski, J., Robert, A.M., Maczar, M. Biochem. Pharmacol, (33)21.
1984. pp. 3491-3497.
Chang, W.C., Hsu, F.L. Inhibition of platelet aggregation and
arachidonate metabolism in platelets by procyanidins. Prostagland
Leukotri Essent Fatty Acids, 38:181-8, 1989.
Masquelier, J. Pycnogenols: recent advances in the therapeutical
activity of procyanidins. Supplement of Planta Medica, Journal
of Medicinal Plant Research and Journal of Natural Products, July
1980 pp. 243-256.
Henning, B., et al. Lipid peroxidation and endothelial cell injury:
implications in atherosclerosis. Free Rad Path & Med, (4)1988
pp. 99-106.
Masquelier, J. “Les procyanidols du vin leur role dans l’alcoolisme.”
pp. 88-93.
Gazave, J.M. “Notions recentes sur les capillaires”
unpub. bulletin from the Laboratoire De Physiologie Patholigie
pp. 26-29.
Ruf, J.C. Wine and polyphenols related to platelet aggregation
and atherothrombosis. Office International Vigne et du Vin, Nutrition
and Health Unit, Paris France; Drugs under Experimental and Clinical
Research (Switz.) 25/2-3 (125-131), 1999.
Blaszo, G. Gabor, M. Oedema-inhibiting effect of procyanidin.
Acta Physiologica Academiae Scientiarum Hungaricae, Tomus 56(2):235-240,
1980.
Tayau, M.F, LeFevre, G. Action du leucocyanidol sur l’hyalaluronidase.
Bull Soc Pharm Bordeaux, 95:132-136, 1956.
Lamy, M. Utilization des oligomeres procyanidoliques en gynecologie.
Essai Therapeutique Tomel (14) Sept. 2, 1981. pp. 1021-22.
Henriet, J.P “Une Etude Exemplaire Pour Un Phlebotrope: l’etude
EIVE.’ Unpub., pp. 77-83.
Pfister, A., Simon, M.T., Gazave, J.M. Sites de fixation des oligomeres
procyanidoliques dans la paroi des capillaires sanguins du poumon
decobaye. Acta Therapeutica (8) 1982. pp. 223-237.
Kuttan, R., Donnelly, P., Di Ferrante, N. “Collagen treated
with (+) -catechin becomes resistant to the action of mammalian
collagenase.” Laboratory of Connective Tissue Research, Dept.
of Biochem. Baylor Col. of Med., Houston TX. 28, May, 1980.
Gendre, P., Laparra, J., Barraud, E. “Effect protecteur des
oligomeres procyanidoliques sur le lathyrisme experimental chez
le rat.” Ann. Pharm. Francaises, (43)1, 1985 pp. 61-73.
Corbe, C., Boissin, J.P., Siou, A. Light vision and chorioretinal
circulation. Study of the effect of procyanidolic oligomer (Endotelon).
Jn. Fr. Opthalmol, (11)5:453-460, 1988.
Boissin, J.P., Corbe C., Siou, A. Chorioretinal circulation and
dazzling: use of procyanidol oligomers (Endotelon). Bull Soc Ophtalmol
Fr, 88(2):173-4, 177-9, 1988.
Proto, F. et al. Electrophysical study of vitis vinifera procyanoside
oligomers effects on retinal function in myopic subjects. Ann
Ott Clin Ocul, 114:85-93, 1988.
Saracco, J.B., Estachy, G.M. Etude d l’Endotelon en opthalmologie.
Gaz Med de France, 88:2035-2038, 1981.
Scharrer, A., Ober, M. Anthocyanosides in the treatment of retinopathies.
Klin Monatsbl Augenheilkd, 178:386-389, 1981.
Corbe, C., et al. Microangiopathy of the retina. J. Fr. Opthalmol,
11:453, 1988.
Verin, M.M., Vildy, A., Maurin, J.F., Retinopathies et O.P.C.
Bordeaux Medicale, (16)11. pp. 1467-74, 1978.
Soyeux, A. et al. Endotelon. Diabetic retinopathy and hemorheology.
Bull Soc Ophtalmol Fr. 87(12):1441-4, 1987.
Fromantin, M. “Les oligomeres procyanidoliques dans le traitement
de la fragilite capillaire et de la retinopathie chez les diabetiques.
A propos de 26 cas.” Med Int, 16(11):432-434, Nov. 1981.
Arne, J.L. Contribution a l’etude des oligomeres procyanidoliques:
Endotelon, dans la retinopathie diabetique (a propos de 30 observations).
Gaz. Med. de France, Vol. 89, No. 30, Oct. 8, 1982.
Baruch, J. Effect of Endotelon in postoperative edema. Results
of a double-blind study versus placebo in 32 female patients.
Ann Chir Plast Esthet 29(4):393-5, 1984.
Rao, C.N. et al. Influence of bioflavonoids on the collagen metabolism
in rats with adjuvantinduced arthritis. Ital J Biochem. 30:54-62,
1981.
Gabor, M. Pharmacologic effects of flavonoids on blood vessels.
Angiologica, 9:355-374, 1972.
Havsteen, B. Flavonoids, a class of natural products of high pharmacological
potency. Biochem Pharmacol, 32:1141-48, 1983.
Reimann, H.J., Lorenz, W., Fischer, M., Frölich, R., Meyer,
H.J. Berkhauser Verlag, Vol. 7/1, Univ. of Marburg/Lahn, Ger.,
1977.
Masquelier, J. Action protectrice du vin sur l’ulcere gastrique.
Resultats, p. 61.
Amella, M., et al. Inhibition of mast cell histamine release by
flavonoids and bioflavonoids. Planta Medica, 5116-20, 1985.
Packer, L., et al. The antioxidant miracle: your complete plan.
John Wiley & Sons, Inc., 1999.
Shaw, R. How [Australian] PycnoGenol [MASQUELIER’s®]
Helps Sports People.
Masquelier, J. Procyanidolic oligomers (leucocyanidins). Parfums
Cosmet Arom 95:89-97, 1990.
Pecking, A., Desprez-Curely, J.P., Megret, G. Oligomers procyanidoliques
(Endotelon) dans le traitement des lymphoedemes post-therepeutiques
de members superieurs. Symposium Satellite, Congres International
d’Angiologie, Toulouse, France, 4-7 Oct. 1989.
Fahey, T.D., Pearl M. Hormonal effects of phosphatidylserine during
2 weeks of intense training. Abstract submitted to national meeting
of the Amer College of Sports Medicine, June 1998.
Monteleone, P., Maj, M., Beinat, L., Natale, M., Kemali, D. Blunting
by chronic phosphatidylserine administration of the stress-induced
activation of the hypothalamo-pituitary-adrenal axis in healthy
men. Eur J Clin Pharm 43: 385–388, 1992.
Fahey, T.D., et al. The hormonal and perceptive effects of phosphatidylserine
administration during two weeks of resistive exercise-induced
overtraining. Bio of Sport 15(3):135-44, 1998.
Laparra, J., Michaud, J. Masquelier, J. Action des oligomeres
procyanidoliques sur le cobaye carence en vitamin c. Tavaux Originaux,
University of Bordeaux, 1976.
Masquelier, J. Action comparee de divers facteurs vitaminiques
p sur l’oxydation de l’acide ascorbique par les ions
cuivriques. Bull. de la Societe de Chimie Biologique XXXIII (3-4)
1951. pp. 302-304.
Masquelier, J. Action comparee de divers facteurs vitaminiques
p sur l’acide ascorbique-oxydase. Bull. de la Societe de
Chimie Biologique XXXIII (3,4) 1951. pp.304-306
Kakegawa, H., Matsumoto, H., Endo, K., Satoh, T., Nonaka, G.,
Mishioka, I. “Inhibitory effects of tannins on hyaluronidase
activation and on the degranulation from rat mesentery mast cells.”
Chem. Pharm. Bull. 33(11)1985. 5079-5082.
Reiman, H.J., Lorenz, M., Fischer, R., Frolich, H., Meyer, J.
“Histamine and acute haemorrhagic lesions in rat gastric
mucosa: prevention of stress ulcer formulation by (+)-catechin,
an inhibitor of specific histidine decarboxylase in vitro.”
Dirkhauser Verlag,Vol. 7/1, 1977.
Pariente, J.J. Parientl-Amsellem, J. “Les oedemes post-traumatoqies
chez le sportif: essai controle de l’Endothelon.” Actualite
Therapeutique 90(3) 2/11 1983 pp. 231-235.
Masquelier, J., et al. “Flavonoids et Pycnogenols” Int
J Vit Nut Res, (49)3:307-311, 1979.
Yu, C. L. et al. Mutagenicity of proanthocyanidins. Food Chem.
Toxicol. 25(2):135-9, 1987.
Pantaleoni, G.C., Quaglino, D. Univerisity of Aquila Pharmacol-Toxicologica
Report, 1971.
Laparra, J., et al., Acta Therapeutica, 4:233, 1978.
Volkner, Wolfgang Muller, Ewald, Micronucleus assay in bone marrow
cells of the mouse with Pycnogenol. Cytotest Cell Research GmbH
& Co., projects 143010 & 143021; Feb. 1989.
Acute and chronic toxicity tests. International Bio-Research,
Inc., Hanover, Germany, 1967-1971.
Dumon, M., Michaud, J., Masquelier, J. Proanthocyanidin content
in vegetable extracts to be used in the preparation of medicines.
Bull. Soc. Pharm. Bordeaux, 129:51-65, 1990.
